Bispecific Antibodies CDMO Market Surges with AI-Driven Innovation to Reach New Heights by 2034
HealthcareA robust CAGR and growing demand for targeted therapies set stage for transformative growth of bispecific antibody contract development and manufacturing across global markets The global bispecific antibodies Contract Development and Manufacturing Organization (CDMO) market is projected to witness significant growth from 2025 to 2034, fueled by the rising demand for precision-targeted cancer and autoimmune […]